Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program

Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

Philip N. Patsalos, David J. Berry, Blaise F. D. Bourgeois et al. · Epilepsia · 2008 · 1.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase <scp>III</scp> randomized, double‐blind, placebo‐controlled trial

Victor Biton, Samuel F. Berkovic, Bassel Abou‐Khalil et al. · Epilepsia · 2013 · 251 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties

Michel Gillard, B. B. Fuks, Karine Leclercq et al. · European Journal of Pharmacology · 2011 · 248 citations

Medicine, Neuroscience, Pharmacology +11

A randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial‐onset seizures

Pavel Klein, Jimmy Schiemann, Michael R. Sperling et al. · Epilepsia · 2015 · 236 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double‐blind, randomized, placebo‐controlled trial

Philippe Ryvlin, Konrad J. Werhahn, Barbara Błaszczyk et al. · Epilepsia · 2013 · 230 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14